Safety of chloral hydrate sedation in dental practice for children: an overview.
Sol SongMi-Ran HanJong-Bin KimPublished in: Journal of dental anesthesia and pain medicine (2020)
Chloral hydrate is the oldest and most common sedative drug used in moderate sedation for pediatric dental patients. Hence, the purpose of this article is to review the safety and possible adverse events of this drug when used for pediatric dental treatment. A bibliographic search in PubMed, MEDLINE, Cochrane Library and KMbase, KISS, DBpia, KoreaMed, and RISS databases was performed. Using the keywords "dental sedation," "chloral hydrate," and "children or adolescent," 512 scientific articles were found. Subsequently, 183 studies were individually assessed for their suitability for inclusion in this literature review. Altogether, 24 studies were selected. They included 12 cases of death before, during, or after chloral hydrate sedation for dental treatment, majorly due to dosing error and use of multiple sedatives. Additionally, intraoperative adverse events were mostly respiratory problems such as hypoxia and apnea, but most events were temporary. After treatment, prolonged sedation, including excessive sleep and less activity were the most common postoperative adverse events, and even death cases were reported. Despite the wide acceptance of chloral hydrate as a sedative-hypnotic agent, the risk of adverse events and adequate dose should be of great concern when using it for pediatric dental sedation.
Keyphrases
- oral health
- mechanical ventilation
- young adults
- healthcare
- primary care
- patients undergoing
- end stage renal disease
- obstructive sleep apnea
- newly diagnosed
- intensive care unit
- ejection fraction
- chronic kidney disease
- high intensity
- weight gain
- childhood cancer
- extracorporeal membrane oxygenation
- positive airway pressure